Quick Answer
PLUS THERAPEUTICS, INC. reported Total Assets of $16.33 million for the year ending 2025.
- PLUS THERAPEUTICS, INC. showed an increase of +146.1% in Total Assets from 2024 to 2025.
- This data is from PLUS THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $48.76 million | Q3 2011: $55.57 million | Q1 2012: $49.10 million | Q2 2012: $40.50 million | Q3 2012: $32.01 million | Q1 2013: $33.37 million | Q2 2013: $39.76 million | Q3 2013: $35.22 million | Q1 2014: $39.42 million | Q2 2014: $38.25 million | Q3 2014: $32.31 million | Q1 2015: $37.05 million | Q2 2015: $46.52 million | Q3 2015: $42.45 million | Q1 2016: $32.92 million | Q2 2016: $42.68 million | Q3 2016: $36.84 million | Q1 2017: $29.77 million | Q2 2017: $32.48 million | Q3 2017: $26.45 million | Q1 2018: $26.64 million | Q2 2018: $22.68 million | Q3 2018: $25.53 million | Q1 2019: $24.62 million | Q2 2019: $8.88 million | Q3 2019: $25.72 million | Q1 2020: $20.97 million | Q2 2020: $13.90 million | Q3 2020: $11.65 million | Q1 2021: $18.34 million | Q2 2021: $20.83 million | Q3 2021: $24.75 million | Q1 2022: $24.52 million | Q2 2022: $21.27 million | Q3 2022: $23.10 million | Q1 2023: $15.64 million | Q2 2023: $14.20 million | Q3 2023: $13.28 million | Q1 2024: $5.62 million | Q2 2024: $11.21 million | Q3 2024: $6.98 million | Q1 2025: $12.06 million | Q2 2025: $10.35 million | Q3 2025: $18.67 million.
- Over the full 16 years of available data (2010 to 2025), PLUS THERAPEUTICS, INC.'s Total Assets has declined by 75.4%.
- Historical annual values: Fiscal year 2025: $16.33 million | Fiscal year 2024: $6.63 million | Fiscal year 2023: $11.39 million | Fiscal year 2022: $23.87 million | Fiscal year 2021: $21.98 million | Fiscal year 2020: $12.11 million | Fiscal year 2019: $23.23 million | Fiscal year 2018: $23.99 million | Fiscal year 2017: $31.62 million | Fiscal year 2016: $34.61 million | Fiscal year 2015: $37.70 million | Fiscal year 2014: $38.72 million | Fiscal year 2013: $42.06 million | Fiscal year 2012: $43.25 million | Fiscal year 2011: $51.53 million | Fiscal year 2010: $66.35 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: